+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Emerging Pharmaceuticals Companies in China

  • PDF Icon

    Report

  • 98 Pages
  • September 2024
  • Region: China
  • AMID Co
  • ID: 3453704

China's Demand for Emerging Pharmaceuticals Will Continue to Grow at 12% by 2033

This study focuses on China’s Emerging Pharmaceuticals industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases.

Table of Contents

INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
EMERGING PHARMACEUTICALS INDUSTRY ASSESSMENTS
  • Emerging Pharmaceuticals Industry Structure
  • Market Size
  • Market Growth Driver
  • Emerging Pharmaceuticals Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development
EMERGING PHARMACEUTICALS PRODUCER DIRECTORY
  • Emerging Pharmaceuticals Producer Profiles and Directory
LIST OF TABLES

INTRODUCTION
  • Economic Outlook Summary
  • Emerging Pharmaceuticals Sales Volume
EMERGING PHARMACEUTICALS INDUSTRY ASSESSMENTS
  • Emerging Pharmaceuticals Sales Volume
  • Major Producer Facility Location
  • Major Emerging Pharmaceuticals Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China
LIST OF CHARTS

INTRODUCTION
  • Economic Outlook Summary
  • China’s Emerging Pharmaceuticals Sales Volume
EMERGING PHARMACEUTICALS INDUSTRY ASSESSMENTS
  • Emerging Pharmaceuticals Sales Volume

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Roche China
  • GlaxoSmithKline China